glutamine and Kidney Neoplasms

glutamine has been researched along with Kidney Neoplasms in 38 studies

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-19907 (18.42)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's17 (44.74)24.3611
2020's14 (36.84)2.80

Authors

AuthorsStudies
Chen, J; Dang, R; Emberley, E; Gross, M; Huang, T; Li, W; MacKinnon, A; Pan, A; Parlati, F; Singh, D; Sotirovska, N; Steggerda, SM; Wang, T1
Enokida, H; Fukumoto, W; Inoguchi, S; Kawakami, I; Matsushita, R; Nakagawa, M; Okamura, S; Osako, Y; Sakaguchi, T; Tamai, M; Tatarano, S; Yamada, Y; Yoshino, H1
Akella, L; Bendell, J; Emamekhoo, H; Fan, AC; Gartrell, BA; Goodman, OB; Hsieh, JJ; Hussain, A; Kalebasty, AR; Lee, CH; Liu, S; Matrana, M; McCune, S; Motzer, R; Nikolinakos, PG; Orford, K; Parmar, H; Patel, V; Percent, I; Shaheen, M; Tannir, NM; Vaishampayan, U; Zakharia, Y; Zhang, Z1
Becker, M; Bedke, J; Büttner, FA; Fend, F; Haag, M; Hennenlotter, J; Hofmann, U; Klumpp, V; Leuthold, P; Menig, LS; Rausch, S; Reustle, A; Schaeffeler, E; Scharpf, M; Schmees, C; Schwab, M; Stenzl, A; Stühler, V; Winter, S1
Dankó, T; Krencz, I; Mészáros, K; Moldvai, D; Pápay, J; Petővári, G; Raffay, R; Sebestyén, A; Sebestyén, E; Sztankovics, D; Végső, G; Vetlényi, E1
Wang, L; Wang, Y; Wu, J; Yang, L1
Ahumada, K; Boroughs, LK; Brugarolas, J; Cai, F; Chiang, JC; DeBerardinis, RJ; Do, QN; Faubert, B; Genovese, G; Kapur, P; Kaushik, AK; Li, X; Mathews, TP; Merritt, M; Pachnis, P; Ragavan, M; Rao, AD; Rosales, T; Saatchi, F; Slusher, BS; Stevens, C; Sun, X; Tarangelo, A; Tcheuyap, VT; Vu, H; Wu, CY; Yong, C; Zacharias, LG; Zhang, Y1
Wang, M1
Chen, H; Deng, Z; Huang, K; Liang, H; Wu, K; Wu, R1
He, B; He, CJ; Jiang, H; Li, AM; Li, Y; Ye, J; Zhou, MN1
Eichelmann, H; Eskla, KL; Hüva, A; Jagomäe, T; Laisk, A; Luuk, H; Oja, V; Porosk, R; Rämma, H; Roberts, J; Tennant, DA; Thakker, A; Vasar, E; Vellama, H; Volke, V1
Chen, Y; Li, D; Liang, Y; Liang, Z; Ma, G; Niu, H; Tian, D; Wang, L; Wang, X; Yang, X1
Baltazar, F; Henrique, R; Jerónimo, C; Lameirinhas, A; Miranda-Gonçalves, V1
Guan, X; Guo, L; Kai, J; Liu, Y; Lu, R; Tong, Y; Wang, S; Wang, Y; Xie, S; Yu, Y; Zheng, H; Zhu, K1
Chaves, F; Christodoulou, D; Gameiro, PA; Iliopoulos, O; Laviollette, L; Lee, R; Okazaki, A; Schneider, M; Stemmer-Rachamimov, A; Stephanopoulos, G; Yazinski, SA; Zou, L1
Abu Aboud, O; Chaudhari, AJ; Habib, SL; Liang, S; Stewart, B; Sutcliffe, J; Trott, J; Weiss, RH1
Weiss, RH1
Chang, Y; Dai, B; Fu, H; Fu, Q; Hu, B; Jiang, Q; Liu, Z; Qi, Y; Tong, S; Wang, T; Wang, Y; Xie, H; Xu, J; Xu, L; Zeng, H; Zhang, J; Zhang, W; Zhou, L; Zhou, Q; Zhu, Y1
Bradley, CA1
Faiena, I; Shuch, B; Ueno, D1
Acker, T; Aragonés, J; Böğürcü-Seidel, N; Bouthelier, A; De Bock, K; Elorza, A; Escasany, E; Fendt, SM; Fraga, E; Fuertes, E; Giménez-Bachs, JM; Hernansanz-Agustín, P; Li, QOY; Lorendeau, D; Martínez-Ruiz, A; Meléndez-Rodríguez, F; Mesa-Ciller, C; Ortega Muelas, M; Pérez, B; Rinaldi, G; Roche, O; Salinas-Sánchez, AS; Sánchez Prieto, R; Tello, D; Torres-Capelli, M; Turiel, G; Urrutia, AA1
Desimone, MC; Rathmell, WK; Threadgill, DW1
Caroen, SZ; Fanger, GR; Lybeck, M; Oronsky, BT; Oronsky, N; Parker, CW; Scicinski, JJ1
Adam, SJ; Bellovin, DI; Casey, SC; Dang, CV; Dang, VM; Eberlin, LS; Felsher, DW; Gabay, M; Garcia-Ocana, A; Gouw, AM; Li, Y; Philbrick, WM; Shroff, EH; Tran, PT; Zare, RN1
Felsher, DW; Gouw, AM; Toal, GG1
Crooks, DR; Linehan, WM; Ricketts, CJ; Schmidt, LS; Sourbier, C; Srinivasan, R1
Choi, J; Choi, KH; Han, WK; Kang, HG; Kim, KS; Koh, E; Lee, HW; Lee, YS; Yoon, YE1
Chatterjee, A; Foster, DA; Mroz, V; Ohh, M; Patel, D; Salloum, D; Saqcena, M1
Adam, J; Chaneton, B; Deberardinis, RJ; Folger, O; Frezza, C; Gottlieb, E; Hedley, A; Jerby, L; Kalna, G; MacKenzie, ED; Micaroni, M; Pollard, PJ; Rajagopalan, KN; Ruppin, E; Shlomi, T; Tomlinson, IP; Watson, DG; Zheng, L1
Chandel, NS; Chen, PH; Cheng, T; DeBerardinis, RJ; Jin, ES; Linehan, WM; Mullen, AR; Sullivan, LB; Wheaton, WW; Yang, Y1
Bell, EL; Gameiro, PA; Guarente, L; Hiller, K; Iliopoulos, O; Irvine, DJ; Jewell, CM; Johnson, ZR; Kelleher, JK; Mattaini, KR; Metallo, CM; Stephanopoulos, G; Vander Heiden, MG; Yang, J1
Boritzki, TJ; Jackson, RC; Morris, HP; Weber, G1
Aoki, T; Morris, HP; Weber, G1
Morris, HP; Prajda, N; Weber, G1
Baechtel, FS; Prager, MD1
Marquez, J; Medina, MA; Nuñez de Castro, I; Perez-Rodriguez, J; Quesada, AR; Sanchez-Jimenez, F1
Greengard, O; Richards, TC1
Katunuma, N; Weber, G1

Reviews

3 review(s) available for glutamine and Kidney Neoplasms

ArticleYear
The metabolic landscape of urological cancers: New therapeutic perspectives.
    Cancer letters, 2020, 05-01, Volume: 477

    Topics: Carcinoma, Renal Cell; Glucose; Glutamine; Humans; Kidney Neoplasms; Lipid Metabolism; Male; Prostatic Neoplasms; Urologic Neoplasms

2020
Metabolomics and Metabolic Reprogramming in Kidney Cancer.
    Seminars in nephrology, 2018, Volume: 38, Issue:2

    Topics: Adaptation, Physiological; Arginine; Carcinoma, Renal Cell; Fatty Acids; Glutamine; Glycolysis; Humans; Kidney Neoplasms; Lipids; Metabolic Networks and Pathways; Metabolomics; Tryptophan

2018
Follow the ATP: tumor energy production: a perspective.
    Anti-cancer agents in medicinal chemistry, 2014, Volume: 14, Issue:9

    Topics: Adenosine Triphosphate; Autophagy; Carrier Proteins; Energy Metabolism; Glucose; Glucose Transporter Type 1; Glutamine; Hexokinase; Humans; Kidney Neoplasms; Membrane Proteins; NAD; Neoplasms; Pentose Phosphate Pathway; Thyroid Hormone-Binding Proteins; Thyroid Hormones

2014

Trials

1 trial(s) available for glutamine and Kidney Neoplasms

ArticleYear
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, 08-02, Volume: 28, Issue:15

    Topics: Angiogenesis Inhibitors; Carcinoma, Renal Cell; Everolimus; Glutaminase; Glutamine; Humans; Kidney Neoplasms; Protein Kinase Inhibitors; Sirolimus

2022

Other Studies

34 other study(ies) available for glutamine and Kidney Neoplasms

ArticleYear
The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma.
    PloS one, 2021, Volume: 16, Issue:11

    Topics: Anilides; Animals; Benzeneacetamides; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Everolimus; Female; Gene Expression Regulation, Neoplastic; Glucose; Glutaminase; Glutamine; Humans; Kidney Neoplasms; Mice; Pyridines; Signal Transduction; Thiadiazoles; Xenograft Model Antitumor Assays

2021
Targeting of the glutamine transporter SLC1A5 induces cellular senescence in clear cell renal cell carcinoma.
    Biochemical and biophysical research communications, 2022, 06-30, Volume: 611

    Topics: Amino Acid Transport System ASC; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Kidney Neoplasms; Minor Histocompatibility Antigens; RNA, Small Interfering

2022
Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma.
    Clinical and translational medicine, 2022, Volume: 12, Issue:6

    Topics: Carcinoma, Renal Cell; Deoxyglucose; Glucose; Glutamine; Humans; Kidney Neoplasms; Niacinamide; Tumor Microenvironment

2022
Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics.
    International journal of molecular sciences, 2022, Sep-13, Volume: 23, Issue:18

    Topics: Carcinoma, Renal Cell; Citrates; Glutamine; Humans; Kidney Neoplasms; Lactates; Malates; MTOR Inhibitors; Pyruvates; RNA, Messenger; Sirolimus; TOR Serine-Threonine Kinases

2022
Circ_0000069 contributes to the growth, metastasis and glutamine metabolism in renal cell carcinoma (RCC) via regulating miR-125a-5p-dependent SLC1A5 expression.
    Transplant immunology, 2023, Volume: 77

    Topics: Amino Acid Transport System ASC; Animals; Carcinoma, Renal Cell; Cell Proliferation; Glutamine; Humans; Kidney Neoplasms; Mice; MicroRNAs; Minor Histocompatibility Antigens

2023
In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma.
    Science advances, 2022, 12-16, Volume: 8, Issue:50

    Topics: Animals; Carcinoma, Renal Cell; Glutaminase; Glutamine; Humans; Isocitrate Dehydrogenase; Kidney Neoplasms; Mice

2022
Targeting glutamine use in RCC.
    Nature reviews. Nephrology, 2023, Volume: 19, Issue:3

    Topics: Carcinoma, Renal Cell; Cell Proliferation; Glutamine; Humans; Kidney Neoplasms

2023
Renal enhanced CT images reveal the tandem mechanism between tumor cells and immunocytes based on bulk/single-cell RNA sequencing.
    Functional & integrative genomics, 2023, Mar-18, Volume: 23, Issue:2

    Topics: Carcinoma, Renal Cell; Glutamine; GTPase-Activating Proteins; Humans; Kidney Neoplasms; Sequence Analysis, RNA; Tomography, X-Ray Computed; Tumor Microenvironment

2023
Mitochondrial Uncoupling Inhibits Reductive Carboxylation in Cancer Cells.
    Molecular cancer research : MCR, 2023, 10-02, Volume: 21, Issue:10

    Topics: Carcinoma, Renal Cell; Glutamine; Humans; Kidney Neoplasms; NAD

2023
VHL-deficiency leads to reductive stress in renal cells.
    Free radical biology & medicine, 2023, 11-01, Volume: 208

    Topics: Carcinoma, Renal Cell; Glutamine; Humans; Kidney Neoplasms; Up-Regulation; Von Hippel-Lindau Tumor Suppressor Protein

2023
Glutamine Deprivation Induces PD-L1 Expression via Activation of EGFR/ERK/c-Jun Signaling in Renal Cancer.
    Molecular cancer research : MCR, 2020, Volume: 18, Issue:2

    Topics: B7-H1 Antigen; Cell Line, Tumor; ErbB Receptors; Gefitinib; Glutamine; Humans; Interferon-gamma; JNK Mitogen-Activated Protein Kinases; Kidney Neoplasms; MAP Kinase Signaling System; Neoplasm Staging; Protein Kinase Inhibitors; RNA, Small Interfering; Signal Transduction; T-Lymphocytes; Up-Regulation

2020
VHL regulates the sensitivity of clear cell renal cell carcinoma to SIRT4-mediated metabolic stress via HIF-1α/HO-1 pathway.
    Cell death & disease, 2021, 06-16, Volume: 12, Issue:7

    Topics: Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glutamine; Heme Oxygenase-1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Neoplasms; Mitochondrial Proteins; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Reactive Oxygen Species; Signal Transduction; Sirtuins; Von Hippel-Lindau Tumor Suppressor Protein

2021
Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers.
    The Journal of clinical investigation, 2017, May-01, Volume: 127, Issue:5

    Topics: Animals; Carcinoma, Renal Cell; Glutamates; Glutaminase; Glutamine; Humans; Kidney Neoplasms; Mice; Mice, Nude; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species; S Phase Cell Cycle Checkpoints; Von Hippel-Lindau Tumor Suppressor Protein; Xenograft Model Antitumor Assays

2017
Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging.
    Cancer research, 2017, 12-01, Volume: 77, Issue:23

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Benzeneacetamides; Carcinoma, Renal Cell; Deoxyguanosine; Glutaminase; Glutamine; Humans; Kidney Neoplasms; Mice; NF-E2 Transcription Factor; Oxidative Stress; Reactive Oxygen Species; Thiadiazoles; Xenograft Model Antitumor Assays

2017
Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion.
    European urology, 2019, Volume: 75, Issue:5

    Topics: Animals; Antibodies; Carcinoma, Renal Cell; Cell Proliferation; Cells, Cultured; Gene Ontology; Glutamine; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immune Evasion; Immune Tolerance; Interleukin-23; Kidney Neoplasms; Lymphocyte Activation; Macrophages; Mice; Oncogene Addiction; Survival Rate; T-Lymphocytes, Regulatory; Tumor Escape

2019
IL-23 links glutamine addiction and immune function.
    Nature reviews. Urology, 2018, Volume: 15, Issue:12

    Topics: Glutamine; Humans; Immune Evasion; Interleukin-23; Kidney Neoplasms; Macrophages

2018
Glutamine and the Tumor Immune Microenvironment.
    European urology, 2019, Volume: 75, Issue:5

    Topics: Glutamine; Humans; Immune Evasion; Interleukin-23; Kidney Neoplasms; Macrophages; Tumor Microenvironment

2019
HIF1α Suppresses Tumor Cell Proliferation through Inhibition of Aspartate Biosynthesis.
    Cell reports, 2019, 02-26, Volume: 26, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Aspartate Aminotransferase, Cytoplasmic; Aspartate Aminotransferase, Mitochondrial; Aspartic Acid; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Female; Glutamine; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Neoplasms; Male; Middle Aged; Mitochondrial Proteins; Neoplasms; Oxidation-Reduction; Tumor Suppressor Proteins; Von Hippel-Lindau Tumor Suppressor Protein

2019
Pleiotropic effects of the trichloroethylene-associated P81S VHL mutation on metabolism, apoptosis, and ATM-mediated DNA damage response.
    Journal of the National Cancer Institute, 2013, Sep-18, Volume: 105, Issue:18

    Topics: Animals; Apoptosis; Arginine; Ataxia Telangiectasia Mutated Proteins; Carcinoma, Renal Cell; Cell Cycle Proteins; DNA Damage; DNA-Binding Proteins; Embryonic Stem Cells; Glutamine; Humans; Hypoxia-Inducible Factor 1; Immunohistochemistry; Kidney Neoplasms; Mice; Occupational Exposure; Point Mutation; Proline; Protein Array Analysis; Protein Serine-Threonine Kinases; Serine; Teratoma; Trichloroethylene; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Von Hippel-Lindau Tumor Suppressor Protein

2013
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism.
    Proceedings of the National Academy of Sciences of the United States of America, 2015, May-26, Volume: 112, Issue:21

    Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Genes, myc; Genes, ras; Glutaminase; Glutamine; Humans; Kidney Neoplasms; Lipid Metabolism; Mice; Mice, SCID; Mice, Transgenic; RNA, Messenger; RNA, Neoplasm; Spectrometry, Mass, Electrospray Ionization; Sulfides; Thiadiazoles; Up-Regulation

2015
Metabolic vulnerabilities of MYC-induced cancer.
    Oncotarget, 2016, 05-24, Volume: 7, Issue:21

    Topics: Animals; Carcinoma, Renal Cell; Genes, myc; Glutamine; Kidney Neoplasms; Mice; Oncogenes

2016
SnapShot: Renal Cell Carcinoma.
    Cancer cell, 2016, Apr-11, Volume: 29, Issue:4

    Topics: Carcinoma, Renal Cell; Energy Metabolism; Genes, Neoplasm; Glucose; Glutamine; Glycolysis; Humans; Kidney Neoplasms; Lipids; Neoplasm Proteins; Neoplastic Syndromes, Hereditary

2016
Mitochondrial Sirt3 supports cell proliferation by regulating glutamine-dependent oxidation in renal cell carcinoma.
    Biochemical and biophysical research communications, 2016, 06-03, Volume: 474, Issue:3

    Topics: Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glutamine; Humans; Kidney Neoplasms; Mitochondria; Mitochondrial Proteins; Oxidation-Reduction; Sirtuin 3; Tumor Cells, Cultured

2016
A Late G1 Lipid Checkpoint That Is Dysregulated in Clear Cell Renal Carcinoma Cells.
    The Journal of biological chemistry, 2017, 01-20, Volume: 292, Issue:3

    Topics: Carcinoma, Renal Cell; Cell Membrane; Endoplasmic Reticulum Stress; G1 Phase Cell Cycle Checkpoints; Glutamine; Humans; Kidney Neoplasms; Lipid Metabolism; MCF-7 Cells; Neoplasm Proteins; PTEN Phosphohydrolase; TOR Serine-Threonine Kinases

2017
Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase.
    Nature, 2011, Aug-17, Volume: 477, Issue:7363

    Topics: Animals; Bilirubin; Cell Line; Cells, Cultured; Citric Acid Cycle; Computer Simulation; Fumarate Hydratase; Fumarates; Genes, Lethal; Genes, Tumor Suppressor; Glutamine; Heme; Heme Oxygenase (Decyclizing); Kidney Neoplasms; Leiomyomatosis; Mice; Mitochondria; Mutation; NAD; Neoplastic Syndromes, Hereditary; Skin Neoplasms; Uterine Neoplasms

2011
Reductive carboxylation supports growth in tumour cells with defective mitochondria.
    Nature, 2011, Nov-20, Volume: 481, Issue:7381

    Topics: Acetyl Coenzyme A; Animals; Carcinoma, Renal Cell; Cell Hypoxia; Cell Line, Tumor; Citric Acid; Electron Transport; Electron Transport Complex I; Electron Transport Complex III; Fumarate Hydratase; Glucose; Glutamine; Humans; Isocitrate Dehydrogenase; Kidney Neoplasms; Mice; Mitochondria; NADP; Neoplasms

2011
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia.
    Nature, 2011, Nov-20, Volume: 481, Issue:7381

    Topics: Acetyl Coenzyme A; Aryl Hydrocarbon Receptor Nuclear Translocator; Basic Helix-Loop-Helix Transcription Factors; Carbon; Carcinoma, Renal Cell; CD8-Positive T-Lymphocytes; Cell Hypoxia; Cell Line, Tumor; Cells, Cultured; Citric Acid Cycle; Glutamine; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Isocitrate Dehydrogenase; Ketoglutaric Acids; Kidney Neoplasms; Lipogenesis; Oxidation-Reduction; Oxygen; Palmitic Acid; Von Hippel-Lindau Tumor Suppressor Protein

2011
Guanosine-5'-phosphate synthetase and guanosine-5'-phosphate kinase in rat hepatomas and kidney tumors.
    Biochimica et biophysica acta, 1981, Mar-13, Volume: 658, Issue:1

    Topics: Animals; Carbon-Nitrogen Ligases; Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor; Carcinoma; Glutamine; Guanosine Monophosphate; Guanylate Kinases; Kidney Neoplasms; Ligases; Liver; Liver Neoplasms, Experimental; Liver Regeneration; Male; Neoplasms, Experimental; Nucleoside-Phosphate Kinase; Phosphotransferases; Rats; Tissue Distribution

1981
Regulatory properties and behavior of activity of carbamoyl phosphate synthetase II (glutamine-hydrolyzing) in normal and proliferating tissues.
    The Journal of biological chemistry, 1982, Jan-10, Volume: 257, Issue:1

    Topics: Animals; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Colonic Neoplasms; Glutamine; Humans; Hydrogen-Ion Concentration; Kidney Neoplasms; Kinetics; Ligases; Liver; Liver Neoplasms, Experimental; Male; Neoplasms, Experimental; Rats; Rats, Inbred ACI; Ribonucleotides

1982
Glutamine-phosphoribosylpyrophosphate amidotransferase (amidophosphoribosyltransferase, EC 2.4.2.14) activity in normal, differentiating, and neoplastic kidney.
    Cancer research, 1979, Volume: 39, Issue:10

    Topics: Adenocarcinoma; Age Factors; Amidophosphoribosyltransferase; Animals; Female; Glutamine; Kidney Cortex; Kidney Neoplasms; Kinetics; Magnesium; Male; Neoplasms, Experimental; Pentosyltransferases; Phosphoribosyl Pyrophosphate; Pregnancy; Rats; Tissue Distribution

1979
Human renal carcinoma: asparagine independence with asparaginase susceptibility in culture.
    Cancer letters, 1988, Dec-15, Volume: 43, Issue:3

    Topics: Asparaginase; Aspartate-Ammonia Ligase; Cell Division; Cell Line; Culture Media; Glutamine; Humans; Kidney Neoplasms; Ligases; Protein Biosynthesis; Tumor Cells, Cultured

1988
Purification of phosphate-dependent glutaminase from isolated mitochondria of Ehrlich ascites-tumour cells.
    The Biochemical journal, 1988, Nov-01, Volume: 255, Issue:3

    Topics: Animals; Carcinoma, Ehrlich Tumor; Glutaminase; Glutamine; Hydrogen-Ion Concentration; Immunoblotting; Kidney Neoplasms; Kinetics; Mice; Mitochondria; Molecular Weight; Phosphates; Rats

1988
Distribution of glutamine hexosephosphate aminotransferase in rat tissues; changes with state of differentiation.
    Biochimica et biophysica acta, 1973, May-28, Volume: 304, Issue:3

    Topics: Aging; Animals; Brain; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Cell Differentiation; Female; Fetus; Fructosephosphates; Glucose; Glutamine; Intestines; Kidney; Kidney Neoplasms; Kinetics; Lactation; Liver; Liver Neoplasms; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Muscles; Myocardium; Placenta; Pregnancy; Rats; Rats, Inbred Strains; Rhabdomyosarcoma; Salivary Glands; Transaminases

1973
Glutamine phosphoribosylpyrophosphate amidotransferase: increased activity in hepatomas.
    FEBS letters, 1974, Dec-01, Volume: 49, Issue:1

    Topics: Animals; Carcinoma, Hepatocellular; Glutamine; Kidney; Kidney Neoplasms; Liver; Liver Neoplasms; Liver Regeneration; Male; Neoplasms, Experimental; Pentosephosphates; Pentosyltransferases; Rats; Rats, Inbred Strains; Ribose; Ultracentrifugation

1974
chemdatabank.com